DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
| MO-G-SAN1-0 | Contemporary Pediatric Radiation Therapy: Perspectives From Children's Oncology Group J Breneman1*, P Rassiah-Szegedi2*, M Gopalakrishnan3*, (1) University of Cincinnati, Cincinnati, OH, (2) University Utah, Salt Lake City, UT, (3) Northwestern Memorial Hospital, Chicago, IL |
| PO-GePV-P-6 | Have Benchmarks and Pre-Treatment Reviews Impacted the Clinical Trial Deviation Rate? J Lowenstein*, H Nguyen , J Roll , D Followill , UT MD Anderson Cancer Center, Houston, TX |
| PO-GePV-T-77 | Results of IROC Anthropomorphic Liver Phantom Irradiations with Protons and Photons P Taylor*, P Alvarez , H Mehrens , D Followill , UT MD Anderson Cancer Center, Houston, TX |
| PO-GePV-T-87 | Plan Quality Evaluation Using Simultaneous-Integrated Boost with Photon and Proton Therapy for Glioblastoma: An Initial Dosimetric Investigation Following NRG-BN001 Trial T Cui*, B Liu , J Weiner , R Davis , R Parikh , K Nie , N Yue , Y Zhang , Rutgers Cancer Institute of New Jersey, New Brunswick, NJ |
| PO-GePV-T-118 | IROC Radiation Therapy QA Centers: 5 Years of Support of the NCI's NCTN Clinical Trials D Followill1*, J Michalski2 , T Fitzgerald3 , Y Xiao4 , (1) IROC Houston QA Center, Houston, TX, (2) IROC St Louis QA Center, Saint Louis, MO, (3) IROC Rhode Island QA Center, Lincoln, Rhode Island,(4) IROC Philadelphia QA Center, Philadelphia, PA |
| SU-A-SAN4-0 | AAPM Medical Physics Student Meeting: Patient Communication - A Future Role for Clinical Physicists T Atwood1*, D Brown1*, (1) University of California, San Diego, La Jolla, CA |
| SU-A-SAN4-1 | Why Should Medical Physicists Communicate with Patients? T Atwood1*, D Brown1*, (1) University of California, San Diego, La Jolla, CA |
| SU-A-SAN4-2 | Effective Clinical Communication Strategies T Atwood1*, D Brown1*, (1) University of California, San Diego, La Jolla, CA |
| SU-A-SAN4-3 | Q/A T Atwood1*, D Brown1*, (1) University of California, San Diego, La Jolla, CA |
| TU-C930-GePD-F7-3 | External Validation of 3D Spatial Dose-Response Mapping for Toxicity Subsequent to Pelvic Radiotherapy M Marcello1 , A Kennedy2 , A Haworth3 , L Holloway4,5,6 , J Dowling7,8 , P Greer8,9 , S Gulliford10,11 , D Dearnaley11 , M Sydes12 , E Hall11 , J Denham8,9 , M Ebert1,2*, (1) University Of Western Australia, Perth, Australia,(2) Sir Charles Gairdner Hospital, Perth, Australia,(3) University of Sydney, Camperdown, NSW, Australia, (4) Liverpool Hospital, Sydney, Australia,(5) University of New South Wales, Sydney, Australia,(6) University of Wollongong, Wollongong, ,(7) CSIRO, Brisbane, Australia,(8) University of Newcastle, Newcastle, Australia,(9) Calvary Mater Newcastle, Newcastle, Australia,(10) University College London Hospital, London, London, United Kingdom, (11) Institute for Cancer Research, Sutton, United Kingdom, (12) University College London, London, United Kingdom, |
